Cancer Functional Proteomics

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Oncology".

Deadline for manuscript submissions: closed (15 March 2024) | Viewed by 244

Special Issue Editor


E-Mail Website
Guest Editor
Laboratory of Biological Chemistry, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece
Interests: functional proteomics; cancer biology; neurodegenerative diseases; system biology; bioinformatics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

Despite all the combined efforts of the scientific community, cancer remains a main cause of death affecting millions of people around the world. In cancer research, functional proteomics plays a crucial role in identifying and characterizing the proteins involved in the development, progression, and response to treatment of cancer. It provides insights into the functional alterations that occur in cancer cells compared to normal cells, but also compared to different cancer types and stages, which can aid in the discovery of potential precise and personalized therapeutic targets and biomarkers for early diagnosis, prognosis and monitoring. There are several techniques and approaches used in cancer functional proteomics, including protein expression profiling, protein interaction analysis, and the study of post-translational modifications (PTMs). Understanding how proteins interact with each other is crucial for unraveling the complex network of signaling pathways in cancer. PTMs, such as phosphorylation, acetylation, methylation, and ubiquitination, play a crucial role in regulating protein function and cellular processes; therefore, their study is essential for gaining insights into how these modifications contribute to cancer development and progression. By integrating data from these approaches with other available data, cancer functional proteomics provides a comprehensive understanding of the dynamic proteomic landscape in cancer cells. This knowledge can help identify new therapeutic targets, develop personalized treatment strategies, and improve patient outcomes in the field of oncology. 

We are excited to invite authors to submit original research and review articles that address the progress and current standing of functional proteomics studies in cancer research. Research areas may include various aspects and approaches that have been developed for understanding and predicting the dynamics and alterations of the proteome in the development, progression, and resistance to therapy of different cancers, as well as their potential application in developing precise cancer diagnosis, prognosis and therapies.

Dr. Michalis Aivaliotis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer
  • functional proteomics
  • protein interactions
  • mass spectrometry
  • post-translational modifications
  • biomarkers discovery
  • cancer pathways
  • cancer signaling

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop